The global pharmaceutical industry has contended with many supply challenges in recent years, from the COVID-19 pandemic to ...

It might not be too late to invest in this company.

For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now that approach is being ...

First commercial agreement with a top 5 global pharmaceutical company anchors a growing pipeline of enterprise discussions; runway secured into late 2027GAITHERSBURG, Md., April 13, 2026 (GLOBE ...

Antibiotic resistance is tightening its grip on global healthcare, but the pipeline of truly new treatments remains thin.

AbbVie has agreed to pay $30 million upfront to Haisco Pharmaceutical Group for ex-China rights to two non-opioid pain treatment candidates. | AbbVie has agreed to pay $30 million upfront to Chinese ...

Biotech stocks may offer your portfolio an element of growth, and that's because these companies are sharply focused on innovation. They set out to tackle some of the most challenging diseases, and as ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ('Alterity” or 'the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

This small biotech could grow much larger with some good news from its pipeline.

North Carolina, ranked in the top five states for life sciences by Business Facilities, is home to a thriving ecosystem specializing in bio and pharmaceutical manufacturing. Propelled by a low cost of ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...